From Clinical Studies to “Made in USA”: Marketing Branded Ingredients Without Stepping Over the Line
Asa Waldstein explores the regulatory considerations that shape how branded ingredients can be marketed effectively and responsibly. The session will cover how to translate clinical research into compliant marketing claims, including research involving disease populations, biomarkers, and emerging areas such as nutritional peptides. It will also examine country-of-origin marketing, including “Made in USA” claims and globally sourced ingredients, as well as recent FDA, FTC, and litigation trends affecting ingredient suppliers and the brands they support. Using real-world examples, Asa will highlight common areas of risk and practical ways companies can use credible science and transparent sourcing to strengthen compliant marketing.
















